Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626001278325) titled 'The PROTECT-PD Study: Evaluating Probucol's preliminary efficacy on disease progression in Parkinson's disease - Cohort 2' on Oct. 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Curtin University
Condition:
Parkinson's Disease
Parkinson's Disease
Neurological - Parkinson's disease
Intervention:
PROTECT-PD Cohort 2 is an Open-label, single-arm study evaluating the safety, tolerability, and feasibility of Probucol in individuals with more advanced Pa...